TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SYRE

Spyre Therapeutics Inc.

Healthcare · Biotechnology

92.70$ +1.7% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Spyre Therapeutics Inc. (SYRE): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/03/2026.

Next report 11/03/2026
Last report 08/04/2026
Earnings surprise by quarter (%)
Q3 23 · -1,011.9 % 23 Q4 23 · -419.2 % 23 Q1 24 · -11.1 % 24 Q2 24 · 5.5 % 24 Q3 24 · -58.1 % 24 Q4 24 · 14.2 % 24 Q1 25 · 28.6 % 25 Q2 25 · 31.0 % 25 Q3 25 · 79.7 % 25 Q4 25 · 7.5 % 25 Q1 26 · -14.8 % 26 Q2 26 · 49.3 % 26

EPS estimate beaten

Full history 17 of 42 quarters (40%)
Last 16 quarters 8 of 16 quarters (50%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/08/2026 Spyre Therapeutics, Inc. (SYRE): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/25/2026 Spyre Therapeutics, Inc. (SYRE): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/04/2026 Spyre Therapeutics, Inc. (SYRE): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?